Delveinsight

AUGUST 26, 2021

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion. Seattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Roche to bolster the development of gene therapies for Alzheimer’s and Parkinson’s disease.

Vaccine 98

Vaccine Vaccination Gene Therapy RNA 98

XTalks

SEPTEMBER 25, 2024

NPC is a rare genetic disorder that leads to progressive neurological symptoms and organ dysfunction. It is caused by mutations in either the NPC1 or NPC2 gene, disrupting the normal transport of cholesterol and other lipids within cells. However, some panel members were still not convinced of its efficacy.

Genetics 52

Genetics Drugs Trials Pharmacy 52

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Viral Vectors for Gene Delivery to the CNS. Reporter genes to understand dose and distribution. The patients are waiting!

Trials 83

Trials Drug Delivery Drugs Gene 83

Advarra

JULY 28, 2022

This article explores how these tools work and why biosafety cabinets are preferred in research involving cell and gene therapies. In the case of IBC review, we’re preventing exposure to biologics such as engineered genetic materials and/or infectious agents. What is a Biosafety Cabinet? They operate under negative air pressure (i.e.,

Contamination 52

Contamination Biohazard Biohazard Production 52

The Pharma Data

NOVEMBER 20, 2020

Progeria and Progeroid Laminopathies are separate and distinct ultra-rare, genetic, premature aging diseases that accelerate mortality in young patients. Progeria is caused by a point mutation in the LMNA gene, yielding the farnesylated aberrant protein, progerin.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

XTalks

NOVEMBER 1, 2024

mL, depending on the pharmacy. Why it sold so well: Zolgensma is a gene therapy classified as personalized or precision medicine, as it is designed to address specific issues arising from an individual’s unique genetic code. mL) is around $620 for a supply of 0.25 Price of Zolgensma: Zolgensma has a price of $2.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

The Pharma Data

JANUARY 16, 2021

” He pledged to ramp up vaccination availability in pharmacies, build mobile clinics to get vaccines to underserved rural and urban communities and encourage states to expand vaccine eligibility to people 65 and older, The New York Times reported. variant that has acquired three gene mutations not previously seen together in the virus.

Vaccine 52

Vaccine Vaccination Nurses Packaging 52

pharmaphorum

SEPTEMBER 1, 2020

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the transition towards an industrial and scientific concern, by manufacturing and selling alkaloids.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

Pharmaceutical Technology

APRIL 24, 2023

In an email to this news service, João Conde, PhD, professor at NOVA Medical School, Universidade NOVA de Lisboa, said advances like the mRNA vaccines serve as a testament to the breakthroughs made by science over decades of research at the junction of genetics and nanomedicine. These could feature in the next four to five years.

Drug Delivery 147

Drug Delivery Vaccine Vaccination Research 147

XTalks

SEPTEMBER 14, 2020

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. Several laboratories have already shown that they can detect genetic material from the virus in wastewater.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92